More Articles

Doctors’ perceptions of generics in Guadeloupe and Martinique Generics/Research | Posted 15/06/2018

Doctors in Guadeloupe and Martinique are not hostile towards generics but still mostly prescribe brand-name drugs due to patient preferences, according to a study analysing the perceptions of docto...

WuXi Biologics expands its biologicals manufacturing facilities Biosimilars/General | Posted 15/06/2018

China-based WuXi Biologics, headquartered in Wuxi city of Jiangsu Province, is expanding its biologicals manufacturing capacity with new facilities planned in Ireland, China, Singapore and the US.

Aurobindo and Lannett expand their generics portfolios Generics/News | Posted 15/06/2018

Both Indian generics maker Aurobindo Pharma (Aurobindo) and US generics company Lannett have announced efforts to increase their generics portfolios.

FDA issues guidance on quality considerations for inhaled drugs Guidelines | Posted 15/06/2018

The US Food and Drug Administration (FDA) has issued draft guidance on quality considerations for inhaled drugs.

Regulating biosimilars throughout their life cycle Biosimilars/Research | Posted 08/06/2018

A resolution to increase access to life-saving biologicals was passed in May 2014 at the Sixty-seventh World Health Assembly of the World Health Organization (WHO) [1]. However, there still exist b...

EMA approves adalimumab and trastuzumab biosimilars Biosimilars/News | Posted 08/06/2018

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 1 June 2018 that it had recommended granting marketing authorization for the adalimumab bios...

FDA approval for pegfilgrastim biosimilar Fulphila Biosimilars/News | Posted 08/06/2018

The US Food and Drug Administration (FDA) announced on 4 June 2018 that it had approved its first pegfilgrastim biosimilar.

Generics market failures and non-profit manufacturing Generics/Research | Posted 08/06/2018

Competition usually keeps the price of generics well below that of brand-name drugs. However, when there is little or no competition, generics makers can substantially increase prices, which may le...